Cargando…
Clinical burden of autosomal dominant polycystic kidney disease
There are no specific therapies for autosomal dominant polycystic kidney disease (ADPKD), and clinical data evaluating the effects of non-specific therapies on ADPKD patients are scarce. We therefore evaluated those effects using data from a longitudinal health insurance database collected from 2000...
Autores principales: | Hung, Peir-Haur, Lin, Chien-Hung, Hung, Kuan-Yu, Muo, Chih-Hsin, Chung, Mu-Chi, Chang, Chao-Hsiang, Chung, Chi-Jung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066921/ https://www.ncbi.nlm.nih.gov/pubmed/32096480 http://dx.doi.org/10.18632/aging.102858 |
Ejemplares similares
-
Increased Risk of End-Stage Renal Disease in Patients with Renal Cell Carcinoma: A 12-Year Nationwide Follow-Up Study
por: Hung, Peir-Haur, et al.
Publicado: (2014) -
Patients with urothelial carcinoma have poor renal outcome regardless of whether they receive nephrouretectomy
por: Hung, Peir-Haur, et al.
Publicado: (2016) -
Correlation Between Bladder Pain Syndrome/Interstitial Cystitis and Pelvic Inflammatory Disease
por: Chung, Shiu-Dong, et al.
Publicado: (2015) -
Obturator hernia in autosomal dominant polycystic kidney disease
por: Jung, Jong Hwan, et al.
Publicado: (2018) -
Is combined peritoneal dialysis and hemodialysis redundant? A nationwide study from Taiwan
por: Chung, Mu-Chi, et al.
Publicado: (2020)